Evidence map›Paper›PMID 39096181›Full record

ReviewSkin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)2024

Advances in the treatment of axillary bromhidrosis.

Jianfei Zhang, Pengpeng Han, Feng Yang, Bin Jiang

Abstract readReview
In one paragraph

Review in Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Advances in the treatment of axillary bromhidrosis.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jianfei ZhangDepartment of Burns and Plastic Surgery, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.ORCID https://orcid.org/0000-0001-8972-6454
Pengpeng HanDepartment of Burns and Plastic Surgery, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
Feng YangDepartment of Burns and Plastic Surgery, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
Bin JiangDepartment of Burns and Plastic Surgery, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBromhidrosis, characterized by foul-smelling sweat, is a prevalent condition that significantly affects patients' social and psychological well-being.

methodsThis review presents novel treatment approaches and discusses the pros and cons of various treatment options for axillary bromhidrosis.

resultsExtensive research has explored numerous treatment modalities for bromhidrosis. This article systematically reviews both surgical and nonsurgical interventions utilized in clinical practice.

conclusionBy synthesizing available evidence, this review aims to offer evidence-based recommendations for effectively managing bromhidrosis, considering factors such as treatment efficacy, safety profiles, patient preferences, and clinical outcomes.

Indexed as

AxillaHumansHyperhidrosisOdorantsSweat Gland DiseasesTreatment Outcomeaxillary bromhidrosisetiologytechnological advancestherapy

Identifiers

PMID39096181
PMCPMC11297419

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.